Drug costs

Latest News

AMCP CEO Discusses Adherence, Out-of-Pocket Costs, and Concerns over the Inflation Reduction Act
AMCP CEO Discusses Adherence, Out-of-Pocket Costs, and Concerns over the Inflation Reduction Act

March 6th 2024

In the third part of this video series, Susan Cantrell, CEO of AMCP, discusses the impact of drug prices on patient adherence with Managed Healthcare Executive.

Upended: Can PBM Transparency Succeed?
Upended: Can PBM Transparency Succeed?

March 6th 2024

AMCP’s Susan Cantrell Suggests Collaborative Solutions to Address High Drug Prices and Healthcare Disparities in Underserved Communities
AMCP’s Susan Cantrell Suggests Collaborative Solutions to Address High Drug Prices and Healthcare Disparities in Underserved Communities

March 1st 2024

AMCP CEO Susan Cantrell Addresses Complex Causes of High Drug Prices and Advocates for Multi-Stakeholder Solutions in US Healthcare
AMCP CEO Susan Cantrell Addresses Complex Causes of High Drug Prices and Advocates for Multi-Stakeholder Solutions in US Healthcare

February 29th 2024

Image credit: © wollertz   stock.adobe.com
HHS Needs More Rebate Information To Negotiate Medicare Drug Prices, Say USC Experts

February 19th 2024

Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.